Current status of the hormone therapy during the menopausal transition ans post-menopausa
Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out, such repo...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/27899 |
| Aporte de: |
| Sumario: | Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out, such report with sorne modifications is presented in this publication. The conclusions the experts reached were the foliowing: 1) Hormone Therapy is the goid standard for the control of moderate to severe vasomotor symptorns; 2) this therapy mut be inclicated in an individual manner and only in syrnptomatic women in which the henefit is greater than the risk; 3) the Ieast effective dose rnust be used; 4) it rnust he used neither for cardiovascular prevention, osteoporosis, colon cancer nor for mental disorder; 5) the patient must be informed about the benefits and risks.
|
|---|